← k3vl4r
Log inGet started →

ANVS (Annovis Bio Inc) Price Forecast

AI-generated price forecast for Annovis Bio Inc (ANVS) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of November 2026: K3vl4r's calibrated AI forecast currently reads ANVS as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 0.7740. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

0.7740

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

ANVS forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-61.63%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called ANVS's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest ANVS news

From the market-news feed the forecasts are read against.

  • Annovis Receives Second Positive DSMB Recommendation for its Phase 3 DUET-AD Study · Yahoo · Nov 17
  • Annovis Bio Receives Second Consecutive Positive Recommendation From Independent Data And Safety Monitoring Board For Its DUET-AD Phase 3 Trial In Early Alzheimer's Disease; Six-Month Topline Results On Track For March 2027 · Benzinga · Nov 17
  • Roth Capital Reiterates Buy on Annovis Bio, Lowers Price Target to $3 · Benzinga · Nov 16
  • Annovis Provides Corporate Updates and Reports Third Quarter 2026 Financial Results · Yahoo · Nov 13
  • Annovis Bio Q3 EPS $(0.22) Beats $(0.32) Estimate · Benzinga · Nov 13

🔒

See the full ANVS forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

ANVS forecast — frequently asked

Will ANVS go up?

K3vl4r's calibrated AI forecast currently reads ANVS as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the ANVS price prediction for 2026?

K3vl4r's model projects ANVS toward $0.2837 over the next ~4 weeks, a -61.6% move from $0.7394. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

MGRXARVNCOSMEELVCALCZNTLHALOAGENCOGTAIMCUEEQARDXCGEN

Will ANVS reach…?

Will ANVS reach $1.00?Will ANVS reach $2.00?Will ANVS reach $3.00?Will ANVS reach $5.00?

Or see the full ANVS price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare ANVS

ANVS vs MGRXANVS vs ARVNANVS vs COSMANVS vs EELVANVS vs CALCANVS vs ZNTL

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rResearch libraryTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.